Skip to content
MintByte
§01 · INSIGHTS · INSURANCE · 6 MIN · DEEP DIVE

Critical Illness Cover — Lump-Sum Diagnosis Benefit

Critical illness insurance pays a predefined lump sum on diagnosis of a listed condition (cancer, heart attack, stroke, etc.) — not a reimbursement of actual expenses. IRDAI has standardised a list of covered conditions. Premiums qualify fo

insuranceglossary
Contents
  1. Definition
  2. How the product works
  3. Tax treatment
  4. What to look at (factual framework)
  5. Worked example
  6. See also
  7. Primary source

Definition

Critical illness (CI) cover is a health insurance product that pays a predetermined lump sum directly to the policyholder upon diagnosis of a specified critical illness — irrespective of the actual medical cost incurred. This distinguishes it fundamentally from standard health insurance (mediclaim), which reimburses hospitalisation expenses. IRDAI, through its Standard Health Insurance Product guidelines and Master Circular on Health Insurance Products 2024, has standardised a list of conditions and terminology to improve cross-product comparability. CI cover is available as a standalone policy or as a rider on a base life/term insurance policy.

How the product works

The policyholder selects a cover amount (e.g., ₹25 lakh) and pays an annual premium. On diagnosis of any listed condition and satisfaction of the survival period (typically 30 days post-diagnosis), the insurer pays the full cover amount as a lump sum. The policy may then terminate (single-claim) or continue with the same or reduced cover (multi-claim products exist).

IRDAI-standardised conditions (indicative list under standard CI product):

  • Cancer of specified severity
  • First heart attack of specified severity (myocardial infarction)
  • Open heart replacement or repair of heart valves
  • Coronary artery bypass graft (CABG)
  • Stroke resulting in permanent symptoms
  • Kidney failure requiring regular dialysis
  • Major organ / bone marrow transplant
  • Permanent paralysis of limbs
  • Motor neurone disease with permanent symptoms
  • Multiple sclerosis with persisting symptoms
  • Aorta graft surgery
  • Primary pulmonary arterial hypertension
  • Aplastic anaemia
  • Third-degree burns (≥20% body surface)
  • Coma of specified severity
  • Deafness (permanent irreversible)
  • Loss of speech (permanent irreversible)
  • Loss of limbs
  • Alzheimer's disease of specified severity
  • Parkinson's disease

Products covering more than 20 conditions exist (some cover 60+), but additional conditions beyond the IRDAI-standardised core list may carry insurer-specific definitions — reading the exact definitions is important.

Key exclusion: pre-existing versions of the listed conditions (waiting period typically 90 days to 2 years).

Tax treatment

Section 80D: Premiums paid for critical illness insurance (whether standalone or as a rider on a health policy) qualify under Section 80D, within the ₹25,000/₹50,000 limits applicable to health insurance. If CI is a rider on a life insurance policy (under Section 80C), the treatment follows the base policy deduction — premiums on pure CI standalone plans qualify under 80D.

Section 10(10D): Lump-sum claim proceeds received from a standalone CI policy are treated as a health insurance claim and are generally not taxable as income. However, CI riders on life insurance policies may be governed by the life insurance tax framework — the tax treatment of the rider benefit should be verified in the policy document.

NRIs: premiums paid from NRO accounts qualify for 80D to the extent they relate to Indian-source income; consult a tax adviser for specific structuring.

What to look at (factual framework)

  • Condition definitions: the specific diagnostic criteria matter enormously. "Cancer of specified severity" typically excludes early-stage cancers; "heart attack of specified severity" requires specific enzyme/ECG markers. Reading exact definitions — not just the list — is essential.
  • Survival period: most policies require the insured to survive 30 days after diagnosis for the claim to be payable. Some newer products have waived this.
  • Single vs. multi-claim: some products pay multiple claims for different conditions over the policy term; understand whether cover terminates after first claim.
  • Sum insured adequacy: the lump sum should account not just for treatment cost but also for income replacement during recovery — a frequently cited benchmark is 3–5 years of annual income, though individual needs vary.
  • Standalone vs. rider: standalone CI policies offer more flexibility and typically higher cover amounts than riders; rider CI cover is more convenient but less customisable.

Worked example

Rajesh, 40, earns ₹15 lakh/year and holds a ₹25 lakh standalone CI policy (annual premium ₹8,500). At age 47, he is diagnosed with a major myocardial infarction that satisfies the policy's severity criteria. After the 30-day survival period, the insurer pays ₹25 lakh as a lump sum. Rajesh uses ₹12 lakh for specialised cardiac care and rehabilitation, and keeps ₹13 lakh as income replacement during 8 months of reduced work capacity. His regular health insurance policy (separate mediclaim) simultaneously reimburses the hospitalisation expenses. The two policies operate independently. Tax on the ₹25 lakh proceeds: generally not taxable under the health insurance framework.

See also

Primary source

IRDAI Master Circular on Health Insurance Products 2024 — irdai.gov.in

Disclosure: MintByte Investment Advisers is a SEBI-Registered Investment Adviser (RIA) bearing registration number INA000017633 and SEBI Research Analyst registration number INH000014245, ARN-314872, and APMI APRN-01658. The information on this page is provided for educational and informational purposes only and does not constitute insurance advice. MintByte does not hold an insurance distribution or broking licence. Readers should consult a licensed insurance intermediary and read all policy documents carefully before purchasing any insurance product.

More on insurance

Adjacent reads on the same thesis.

glossary6 min

Demerger (Scheme of Arrangement)

A court-sanctioned restructuring under Companies Act §232 where a business undertaking is transferred to a new or existing company; tax-neut

glossary5 min

Spin-off

A corporate restructuring where a parent company creates a separate, independently listed public entity by distributing shares of a subsidia

glossary5 min

FPO (Follow-on Public Offer)

A subsequent public equity offering by an already-listed company to raise additional capital or enable promoter/investor divestment, governe

glossary5 min

OFS (Offer for Sale)

A SEBI 2012 mechanism enabling large shareholders to sell existing shares via the stock exchange within a compressed 1–2 day window without

Adjacent surfaces

MethodologyHow every metric cited above is derived.GlossaryPlain-language definitions for the terms used.ToolkitWhere these ideas become inputs in calculators.

Data and analytics on this page are educational research, not investment advice. MintByte is an AMFI-registered mutual fund distributor (ARN-314872). MintByte does not issue buy/sell recommendations on specific securities — the site is an educational data and analytics platform. Not investment advice. Methodology · How we earn.